Renosen Pharmaceuticals Private Limited acquired 1,000 equity shares of Senores Pharmaceuticals Limited on August 21, 2025. The disclosure was made under Regulation 29(2) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
Prior to the acquisition, Renosen Pharmaceuticals held 2,705,219 shares, representing 5.87% of the total share/voting capital of Senores Pharmaceuticals Limited. Following the acquisition, the company's holding increased to 2,706,219 shares, representing 5.88% of the total share/voting capital.
The acquisition was made through the open market.
| Particulars | Before Acquisition | After Acquisition | Change |
|---|---|---|---|
| Shares carrying voting rights | 2,705,219 (5.87%) | 2,706,219 (5.88%) | 1,000 (0.002%) |
The equity share capital/total voting capital of Senores Pharmaceuticals Limited before and after the acquisition remains unchanged at 46,053,588 Equity Shares of Rs. 10 Each.
Total diluted share/voting capital of the TC after the said acquisition is 46053588 Equity Shares of Rs. 10 Each.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.
